03

Metro Healthcare Berhad

0329 · KLSE · Healthcare / Medical Care Facilities

0.21MYR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.21
Open0.21
Day Range0.21 – 0.21
52-Week Range0.1977 – 0.245
Volume4.00K
Market Cap205.57M
P/E (TTM)21.00
Forward P/E36.63
EPS0.01
Dividend Yield2.33%
Beta0.19
50-Day Avg0.213
200-Day Avg0.2178

About

Metro Healthcare Berhad, together with its subsidiaries, provides hospital and related services in Malaysia. It offers inpatient; outpatient; and ambulatory care, including in vitro fertilization (IVF), intrauterine insemination (IUI), blastocyst culture, surgical sperm retrieval, preimplantation genetic screening (PGT), and assisted hatching services. The company also provides fertility services, such as assisted reproductive technology and specialized fertility procedures; and obstetrics services that include pre-pregnancy screening and counselling, family planning counselling, antenatal checkup, and delivery services. In addition, it offers gynecology services, including hysterectomy, oophorectomy, colposcopy, hysteroscopy, laparoscopy, tubal ligation, dilation and curettage, and marsupialization; pediatrics services; diagnostic imaging services; and other healthcare services. Metro Healthcare Berhad was founded in 1989 and is based in Klang, Malaysia.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOMr. Wai Khong Lim
  • Employees204
  • HeadquartersNo. 32-38, Jalan Pasar, Klang, Malaysia, 41400, Malaysia
  • Websitehttps://www.metrohealthcare.my

Leadership

  • Mr. Wai Khong LimMD & Director · b. 1967
  • Dr. Swi Peng TayExecutive Vice Chairman · b. 1957
  • Ms. Chiau Chi KhooFinancial Controller · b. 1987
  • Ms. Pei Chin WongMatron & Operations Manager · b. 1968
  • Ms. Sor Hua TeaCompany Secretary · b. 1971
  • Mui Yee ThienJoint Secretary

Financials

Income Statement

Currency: MYR2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue42.26M40.27M44.69M48.65M50.42M
Growth (%)--4.70%+10.96%+8.87%+3.63%
Cost of Revenue22.16M24.27M26.61M28.92M31.46M
Gross Profit20.09M16.01M18.08M19.73M18.96M
Gross Margin47.55%39.74%40.46%40.55%37.61%
Operating Expense11.15M11.95M9.23M12.34M12.04M
Operating Income8.94M4.06M8.85M7.39M6.92M
Operating Margin21.16%10.08%19.79%15.18%13.73%
EBITDA-14.56M14.29M13.30M14.43M
EBITDA Margin-36.15%31.97%27.33%28.63%
Net Income9.44M5.02M6.25M4.56M5.86M
Net Income Margin22.33%12.45%13.98%9.37%11.63%
Interest Expense371.67K398.42K732.40K694.91K618.10K
Interest Expense % of Total Revenue0.88%0.99%1.64%1.43%1.23%

Balance Sheet

Currency: MYR2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets50.24M51.31M59.78M96.03M92.52M
Total Liabilities15.90M16.06M22.40M20.41M17.41M
Total Equity34.34M35.25M37.38M75.62M75.12M
Cash15.26M14.29M15.16M51.41M50.63M

Cash Flow

Currency: MYR2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow12.10M9.25M10.93M9.99M9.07M
Capital Expenditure4.90M4.58M3.55M4.42M1.48M
Free Cash Flow7.21M4.67M7.38M5.58M7.59M
Dividends Paid1.34M4.07M4.32M4.44M6.36M
FCF to OCF59.53%50.51%67.53%55.79%83.70%
Dividend Paid to FCF18.54%87.11%58.47%79.62%83.81%

Earnings

Report DateSep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate--------
EPS Actual0.00-0.000.000.000.000.000.000.00
Surprise--------
Timing--------

Key Statistics & Ratios

Market Cap205.57M
Enterprise Value177.63M
Trailing P/E21.00
Forward P/E36.63
Price / Sales4.02
Price / Book2.80
EPS0.01
Book Value0.077
Revenue (TTM)51.12M
Gross Profit (TTM)19.35M
EBITDA11.19M
Profit Margin13.41%
Operating Margin17.33%
Return on Equity9.24%
Return on Assets5.13%
Shares Outstanding978.93M
Shares Float180.47M
Beta0.19
Dividend Yield2.33%
Dividend Rate0.01
Payout Ratio73.53%

Dividends

20261×
0.00Apr 6, 2026
20252×
0.00Oct 3, 20250.00Apr 10, 2025
20241×
0.01Mar 25, 2024
20231×
0.01Mar 15, 2023
20221×
0.00Apr 5, 2022
20211×
0.00Mar 4, 2021
20201×
0.00Mar 4, 2020
20191×
0.00Jun 27, 2019
20181×
0.00Aug 16, 2018

Stock Splits

  • Oct 7, 20244:3
  • Oct 13, 20213:1